ANTHONY GREGG LAPOINTE
CIK 1331860 · last filed 2026-05-19
ANTHONY GREGG LAPOINTE is a corporate insider who has filed 60 SEC Form 4 insider transactions across 11 companies since 2007. The most recent filing, for RIGL, was dated May 19, 2026. Current disclosed insider exposure totals $599.5K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$599.5K
11
60
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RIGL | Director | 18,250 | $32.85 | $599.5K | $0 | 10 | 2026-05-19 |
| Astria Therapeutics, Inc. (ATXS) Delisted | Director | — | $12.58 | — | $0 | 6 | 2026-01-23 |
| SNGX | Director | — | $0.43 | — | $0 | 4 | 2025-06-20 |
| SOLIGENIX, INC. (SNGXW) Delisted | Director | — | $0.01 | — | $0 | 5 | 2021-09-24 |
| Astria Therapeutics, Inc. (CATB) Delisted | Director | — | $8.54 | — | $0 | 5 | 2021-06-02 |
| SCICLONE PHARMACEUTICALS INC (SCLN) Delisted | Director | — | — | — | $0 | 10 | 2017-10-16 |
| PLUS THERAPEUTICS, INC. (CYTX) Delisted | Director | — | — | — | $0 | 1 | 2017-05-24 |
| Raptor Pharmaceutical Corp (RPTP) Delisted | Director | 0 | — | — | $0 | 4 | 2016-10-26 |
| ImmunoCellular Therapeutics, Ltd. (IMUC) Delisted | Director | — | — | — | $0 | 2 | 2016-06-21 |
| QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted | Director | — | — | — | $0 | 2 | 2010-01-04 |
| QUESTCOR PHARMACEUTICALS INC (QSC) Delisted | Director | — | — | — | $0 | 1 | 2007-01-04 |
Recent Filings
60 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-19 | RIGL | Grant (A) | +5,750 | $0 | EDGAR |
| 2026-01-23 | Astria Therapeutics, Inc. (ATXS) Delisted | Disp (D) | — | $0 | EDGAR |
| 2025-06-20 | SNGX | Grant (A) | — | $0 | EDGAR |
| 2025-06-12 | Astria Therapeutics, Inc. (ATXS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-05-28 | RIGL | Grant (A) | +2,500 | $0 | EDGAR |
| 2024-12-13 | SNGX | Grant (A) | — | $0 | EDGAR |
| 2024-06-06 | Astria Therapeutics, Inc. (ATXS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-05-29 | RIGL | Grant (A) | +25,000 | $0 | EDGAR |
| 2023-12-15 | SNGX | Grant (A) | — | $0 | EDGAR |
| 2023-07-12 | RIGL | Grant (A) | +25,000 | $0 | EDGAR |